Stay updated on Pembrolizumab Combo in Gastro Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Gastro Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag shows v3.6.6 replacing v3.6.5, indicating a software update for the page. It does not alter the study content or its details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor metadata/formatting update to the page. It does not change the study details or content.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3, indicating a small technical update. No study content or user-facing information is changed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision indicator was updated from v3.6.2 to v3.6.3. This indicates a newer version of the study record.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This signals a revision to the page content but does not change the study details.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded new help/navigation sections including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and added the recruitment note 'No longer looking for participants'. The 'Intervention/Treatment' label is introduced while the prior 'Intervention / Treatment' label is removed, and the page revision is updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combo in Gastro Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Gastro Cancer Clinical Trial page.